Articles From: ANGIE'S LIST, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Angie's List, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 21, 2014 -- ANGI to AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results


http://media.marketwire.com/attachments/201107/5424_LeviAndKorsinsky_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1080303&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for ANGIE'S LIST, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Angie's List, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 21, 2014 -- ANGI investment picks
2014/1/17
DALLAS , Jan.
Sign-up for Angie's List, Inc. Stockholders Encouraged to Contact Securities Law Firm about Investigation investment picks
2014/1/9
SAN FRANCISCO (MarketWatch) -- Tech stocks mostly rose in early trading Thursday, with Angie's List Inc. (ANGI) one of the sector's biggest percentage gainers.
Sign-up for Angie's List's rise highlights tech-sector gains investment picks
2013/10/29
ALBANY, N.Y., Oct.
Sign-up for AngioDynamics Achieves CE Approval for AngioVac investment picks
ALBANY, N.Y., Sept.
Sign-up for AngioDynamics Announces Debt Refinancing investment picks
2013/10/3
ALBANY, N.Y., Oct.
Sign-up for AngioDynamics Announces First Patient Enrolled in PICC Related Obstruction of Flow (PROOF) Study investment picks
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics Announces Operational Excellence Program investment picks
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics Appoints John Soto Chief Commercial Officer investment picks
2014/3/20
ALBANY, N.Y., March 20, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced a recent court action in its legal case against biolitec AG.
Sign-up for AngioDynamics Awarded $74.9 Million in Case Against biolitec AG investment picks
2013/9/23
ALBANY, N.Y., Sept.
Sign-up for AngioDynamics Extends Licensing Agreement With Interface Biologics to Include Central Venous Catheters (CVCs) investment picks
2014/3/11
ALBANY, N.Y., March 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) cleared an expanded indication for its AngioVac cannula for venous drainage during extracorporeal bypass for up to six hours to include removal of fresh, soft thrombi or emboli.
Sign-up for AngioDynamics Receives Expanded FDA Clearance for AngioVac investment picks
2014/3/7
ALBANY, N.Y., March 7, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration granted 510(k) clearance for its BioFlo DuraMax chronic hemodialysis catheter.
Sign-up for AngioDynamics Receives FDA Clearance for DuraMax Dialysis Catheter With BioFlo Technology to Reduce Catheter-Related Thrombus investment picks
2013/10/10
Net sales of $83.6 million GAAP net loss of $0.01 per share; Non-GAAP adjusted net income of $0.04 per share; Non-GAAP adjusted net income excluding amortization of $0.12 per share Adjusted EBITDA of $11.3 million Operating cash flow of $7.3 million versus prior year $5.6 million cash use Company raises FY 2014 guidance for revenue and adjusted EPS excluding amortization ALBANY, N.Y., Oct.
Sign-up for AngioDynamics Reports Fiscal 2014 First Quarter Financial Results investment picks
2014/1/9
Net sales of $88.6 million GAAP income per share at break-even; Non-GAAP adjusted net income, excluding amortization, of $0.14 per share Adjusted EBITDA of $12.7 million Operating cash flow of $8.2 million Company raises low end of revenue guidance to $349-$353 million for FY14; reiterates adjusted EPS, excluding amortization, of $0.63-$0.67 ALBANY, N.Y., Jan.
Sign-up for AngioDynamics Reports Fiscal 2014 Second Quarter Financial Results investment picks
2014/4/9
Net sales increase 8% over prior year to $88.2 million GAAP income per share of $0.14; Non-GAAP adjusted net income, excluding amortization, of $0.16 per share Adjusted EBITDA of $14.6 million Company's revenue guidance to $351 million- $355 million for FY14; Adjusted EPS, excluding amortization, of $0.60-$0.63 ALBANY, N.Y., April 9, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the fiscal 2014 third quarter ended February 28, 2014.
Sign-up for AngioDynamics Reports Fiscal 2014 Third Quarter Financial Results investment picks
2013/9/18
ALBANY, N.Y., Sept.
Sign-up for AngioDynamics to Launch Tip Location System in Canada investment picks
2013/11/20
ALBANY, N.Y., Nov.
Sign-up for AngioDynamics to Present at 25th Annual Piper Jaffray Healthcare Conference investment picks
2013/12/18
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference investment picks
ALBANY, N.Y., Aug.
Sign-up for AngioDynamics to Present at 33rd Annual Canaccord Growth Conference investment picks
2014/3/3
ALBANY, N.Y., March 3, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO) , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M.
Sign-up for AngioDynamics to Present at the Barclays Global Healthcare Conference investment picks
ALBANY, N.Y., Aug.
Sign-up for AngioDynamics to Present at the Stifel Nicolaus 2013 Healthcare Conference investment picks
ALBANY, N.Y., Nov.
Sign-up for AngioDynamics to Present at Upcoming Investor Conferences investment picks
ALBANY, N.Y., Sept.
Sign-up for AngioDynamics to Report Fiscal 2014 First Quarter Financial Results investment picks
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ANGIE'S LIST, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Angie's List, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of February 21, 2014 -- ANGI to AngioDynamics to Report Fiscal 2014 Second Quarter Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity